0003-3774 : Opdivo 10 mg/ml Intravenous Injection
NDC: | 0003-3774 |
Labeler: | E.r. Squibb & Sons, L.L.C. |
Product Type: | Human Prescription Drug |
Drug Name: | Opdivo |
Dosage Form: | Intravenous Injection |
Application #: | BLA125554 |
Rev. Date: |
NDC Package Codes:
- 0003-3774-12: 1 VIAL, SINGLE‑USE IN 1 CARTON (0003‑3774‑12) > 10 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Nivolumab
Dosage Strength:
- 10 mg/mL
Pharmaceutical Classes:
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Related Products:
Based on records with the same trade name.- 0003-3734 Opdivo 10 mg/ml Intravenous Injection by E.r. Squibb & Sons, L.L.C.
- 0003-3756 Opdivo 10 mg/ml Intravenous Injection by E.r. Squibb & Sons, L.L.C.
- 0003-3772 Opdivo 10 mg/ml Intravenous Injection by E.r. Squibb & Sons, L.L.C.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0003-3772Next: 0003-4040 >
Related Discussions:
Opdivo (nivolumab) reviews
I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ... 4 replies
I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ... 4 replies
Nivolumab treatments
Does anyone know of hospital in apples fl area offering immunotherapy for cancer namely nivolumab...
Does anyone know of hospital in apples fl area offering immunotherapy for cancer namely nivolumab...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.